MRG003 Combined With Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial

Clinical trial NCT07381699 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07381699
Sponsor: West China Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Cancinoma (NPC)

Start date: 2026-02-01
Primary completion: 2028-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.